Medicamen Biotech (BOM:531146) Other Operating Expense : ₹640 Mil (TTM As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Medicamen Biotech Other Operating Expense?

Medicamen Biotech's Other Operating Expense for the three months ended in Dec. 2023 was ₹184 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was ₹640 Mil.

Medicamen Biotech's quarterly Other Operating Expense increased from Jun. 2023 (₹158 Mil) to Sep. 2023 (₹176 Mil) and increased from Sep. 2023 (₹176 Mil) to Dec. 2023 (₹184 Mil).

Medicamen Biotech's annual Other Operating Expense increased from Mar. 2021 (₹122 Mil) to Mar. 2022 (₹376 Mil) and increased from Mar. 2022 (₹376 Mil) to Mar. 2023 (₹513 Mil).

Medicamen Biotech Other Operating Expense Historical Data

The historical data trend for Medicamen Biotech's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicamen Biotech Other Operating Expense Chart

Medicamen Biotech Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Other Operating Expense

Get a 7-Day Free Trial

112.43

125.20

122.10

375.96

512.69

Medicamen Biotech Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Operating Expense	Get a 7-Day Free Trial															143.28	121.49	158.15	175.68	184.31

Medicamen Biotech Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹640 Mil.

Medicamen Biotech Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Medicamen Biotech's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Medicamen Biotech (BOM:531146) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicamen Biotech Ltd (BOM:531146) » Definitions » Other Operating Expense

Traded in Other Exchanges

MEDICAMEQ:India

Address

1506, Chiranjiv Tower, 43, Nehru Place, New Delhi, IND, 110019

Website

https://www.medicamen.com

Medicamen Biotech Ltd is an Indian based pharmaceutical company. The company is engaged in developing and manufacturing Pharmaceuticals formulations products. It manufactures Tablets, Capsules, Oral liquids, Dry syrups, Ointments, and Oral rehydration solution. The company generates revenue from the sale of pharmaceutical products.

Medicamen Biotech (BOM:531146) Headlines

No Headlines